Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Accelerating Lead Generation Emerging Technologies and Strategies |
Jun 2009 | £2,425 | 100% |
| Radiation Therapy Equipment | Oct 2010 | £2,845 | 94% |
| The Funding Landscape for Small Biopharma Ventures, 2010-2015 Trends, strategies and priorities |
Jul 2010 | £2,425 | 91% |
| The Funding Landscape for Small Biopharma Ventures, 2010-2015 Trends, strategies and priorities |
Jul 2010 | £2,425 | 91% |
| Hanger Orthopedic Group, Inc. Market Share Analysis |
Oct 2010 | £630 | 89% |
| Hanger Orthopedic Group, Inc. Market Share Analysis | Oct 2010 | £630 | 86% |
| BioAlliance Pharma SA – Product Pipeline Review H2 2011 |
Nov 2011 | £315 | 83% |
| Adult and Adolescent Vaccines Market to 2017 Partnerships Increase as Licensing and Co-Development Account for 73% of all Deal-Making Activity in 2010 |
Aug 2011 | £2,215 | 81% |
| Growth Factors (Blood and Tissue) A World Report |
Nov 2009 | £1,895 | 81% |
| Tolerx, Inc. – Product Pipeline Review H2 2011 |
Dec 2011 | £315 | 79% |
| Lead Generation Strategies and Technologies in Drug Development Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize Costs |
Jun 2011 | £2,215 | 79% |
| Sri Lanka Pharmaceuticals and Healthcare Report Q1 2012 |
Jan 2012 | £330 | 78% |
| Advanced Medical Solutions Group plc (AMS) Financial and Strategic SWOT Analysis Review |
May 2011 | £79 | 77% |
| Advancing Molecular Diagnostics to Personalize Cancer Therapy | Jun 2011 | £2,425 | 77% |
| Halozyme Therapeutics, Inc. – Product Pipeline Review H2 2011 |
Nov 2011 | £315 | 76% |
| Drug Discovery in India and China Gaining Momentum with Increasing Pressure on Cost Cutting |
Feb 2010 | £2,215 | 75% |
| Biomanufacturing Strategies Market drivers, build-vs-buy decisions and opportunities in contract relationship management |
Sep 2007 | £1,820 | 75% |
| Melanoma Therapeutics | Apr 2010 | £2,500 | 75% |
| Virtual Pharma The Radical Route To Success |
Sep 2008 | £795 | 75% |
| DARA BioSciences, Inc. – Product Pipeline Review H2 2011 |
Nov 2011 | £315 | 74% |
| Global Disposable Medical Device Market: An Analysis | Dec 2008 | £505 | 74% |
| Leading Drug Delivery Companies and Technologies Competitive landscape, company profiles and technological developments |
Jun 2008 | £2,425 | 74% |
| Key Trends in Offshoring Pharmaceutical R&D Company strategies, emerging markets and impact on ROI |
Mar 2009 | £2,425 | 74% |
| Biomarkers in Drug Discovery Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly |
Oct 2011 | £2,215 | 74% |
| Emerging Pharmaceutical Market in India Strategic Partnerships between Domestic and International Pharmaceutical Players Are The Driving Force |
Aug 2011 | £2,215 | 74% |
| Contraceptives Market to 2017 Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future |
Oct 2011 | £2,215 | 73% |
| Medical Transcription Services | Feb 2010 | £2,435 | 73% |
| Oncology Market in China to 2017 Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market |
Jan 2011 | £2,215 | 72% |
| Drug Discovery Technologies A Global Update of Market Trends & Opportunities |
Nov 2009 | £1,895 | 72% |
| Orthostatic Hypotension - Pipeline Review H2 2011 |
Nov 2011 | £315 | 72% |
